New Published Study Demonstrates Safety and Feasibility of Filterlex Medical’s CAPTIS® Device in Providing Embolic Protection During TAVR

Posted on by

Peer-Reviewed EuroIntervention Journal Publishes First-in-Human Study Finding Filterlex Medical’s CAPTIS® Embolic Protection Device Performed Well and is Safe During Transcatheter Aortic Valve Replacement (TAVR). CAESAREA, Israel, Nov. 15, 2023 /PRNewswire/ — Filterlex Medical Ltd., a…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.